Trading Signals: IOVA Stock Price Prediction and Forecast (Mon. Aug. 10, 2015 - Wed. Sep. 27, 2023)(Iovance Biotherapeutics Inc)
| IOVA latest price $8.8500 (-3.28%) ($8.8350 - $8.8500) on Fri. Oct. 14, 2022. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 4.02% (three month average) | RSI | 44 | Latest Price | $8.8500(-3.28%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | IOVA declines -2.1% a day on average for past five trading days. | Weekly Trend | IOVA declines -4.5% a week on average for past two weeks. | Market Behavior | Broad based sell-off for large cap. Broad based sell-off for small cap. | Correlated ETFs | Broad market will support IOVA advance at 0% a week (0% probability) IBB(37%) IWC(35%) IWO(33%) IWM(31%) IBUY(30%) | Factors Impacting IOVA price | IOVA will decline at least -2.01% in a week (0% probabilities). UUP(-12%) UNG(-12%) TBT(-9%) VXX(-8%) VIXM(-8%) | | | | | Relative Volatility | | | | Market Trend Strength | -2.01% (StdDev 4.02%) | Hourly BBV | -0.6 () | Intraday Trend | 0% | | | |
|
1 - 5 Day Possible Target | $-2.43(-127.46%) | Resistance Level | $9.67 | 5 Day Moving Average | $8.94(-1.01%) | 10 Day Moving Average | $9.36(-5.45%) | 20 Day Moving Average | $9.67(-8.48%) | To recent high | -32.3% | To recent low | 2.5% | Market Cap | $1.296b | | | | Iovance Biotherapeutics, Inc. operates as a biotechnology company. The firm engages in the development and commercialization of novel cancer immunotherapy products. Its lead product candidate, LN-144 for metastatic melanoma, is an autologous adoptive cell therapy utilizing tumor-infiltrating lymphocytes, or TIL, which are T cells derived from patients' tumors. The company was founded by Robert T. Brooke on September 17, 2007 and is headquartered in San Carlos, CA. |